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Mammalian ageing is accompanied by accumulation of genomic DNA damage and progressive decline in the ability of tissues to regenerate 1 . DNA damage activates the tumour suppressor p53, which leads to cell-cycle arrest, senescence or apoptosis. The stability and activity of p53 are induced by DNA damage through posttranslational modifications such as phosphorylation of Thr 21 and Ser 23 (refs 2-5) . To investigate the roles of DNA damage and p53 in tissue-regenerative capability, two phosphorylation-site mutations (T21D and S23D) were introduced into the endogenous p53 gene in mice, so that the synthesized protein mimics phosphorylated p53. The knock-in mice exhibit constitutive p53 activation and segmental progeria that is correlated with the depletion of adult stem cells in multiple tissues, including bone marrow, brain and testes. Furthermore, a deficiency of Puma, which is required for p53-dependent apoptosis after DNA damage 6 , rescues segmental progeria and prevents the depletion of adult stem cells. These findings suggest a key role of p53-dependent apoptosis in depleting adult stem cells after the accumulation of DNA damage, which leads to a decrease in tissue regeneration.
The transcription factor p53 remains in an unstable and inactive state in unstressed cells. Once activated, p53 initiates the transcription of hundreds of genes, including p21, 14-3-3σ , Noxa and Puma 6 , but also suppresses the expression of a number of genes, such as the pluripotency factor Nanog in embryonic stem cells 7 . The transcriptional targets of p53 are responsible for mediating p53-dependent functions. For example, after DNA damage, p21 and 14-3-3σ are required to mediate cell-cycle arrest 8 and Puma is essential for apoptosis 6 . The stability and activity of p53 is regulated primarily through the modulation of the interaction between p53 and its negative regulators Mdm2 or MdmX, which suppress the transcriptional activities of p53 (ref.
3). Additionally, Mdm2 destabilizes p53 by promoting its ubiquitylation and degradation 3 . In response to DNA damage and other cellular stresses, the stability and activity of p53 are significantly increased.
Accumulating evidence indicates that post-translational modifications of p53, such as phosphorylation, are important in regulating p53 stability and activity 9 . Both Thr 18 and Ser 21 of human p53 (corresponding to Thr 21 and Ser 23 of mouse p53) are located within the region that interacts with Mdm2/MdmX, and DNA damage-induced phosphorylation of these residues disrupts the interaction between p53 and Mdm2/ MdmX, leading to p53 activation 9 . Accumulation of DNA damage has been considered as a physiological inducer of ageing 10 . To investigate the role of p53 in the ageing process, we introduced two missense mutations (T21D and S23D) into the endogenous p53 gene in mice; the mutated protein then mimics the phosphorylated p53 induced by DNA damage. The strategy to generate the knock-in mutant mice, denoted as p53 TSD mice, is described in Supplementary Information, Figure S1 . Heterozygous mutant embryonic stem cells with the targeted allele that retained the PGK-Neo r cassette were used to generate chimaeric mice for subsequent germline transmission. As it is well established that the PGK-Neo r gene suppresses the expression of the targeted allele, we initially attempted to excise the LoxP-flanked PGK-Neo r gene from the targeted allele by breeding the heterozygous mice with CMV-Cre transgenic mice that express Cre recombinase during the zygote stage. However, after screening hundreds of offspring, we were unable to identify any animals that had undergone deletion of the PGK-Neo r gene. As the same strategy has been used previously to successfully delete the PGK-Neo r gene from the targeted allele in p53 S18A and p53 S18A/S23A knock-in mice 4, 11 , it seems that p53 TSD could induce embryonic lethality when expressed at normal levels once the PGK-Neo r gene is deleted. Furthermore, when the heterozygous mutant mice with the targeted allele containing the PGK-Neo r cassette were intercrossed, homozygous mutant offspring were rarely obtained, indicating that two copies of the p53 TSD allele induce embryonic lethality ( Supplementary Information, Fig. S1e, top) . To test this potential dosage effect, p53 TSD/+ mice were bred with p53 +/-mice, and p53 TSD/-offspring were observed with a normal Mendelian ratio ( Supplementary Information, Fig.  S1e, bottom) . The entire p53 cDNA derived from p53 TSD/-mouse embryonic fibroblasts (MEFs) was sequenced to verify that only the T21D/S23D substitutions were introduced into the endogenous p53 gene of p53 TSD/-mice.
Additionally, p53 protein was expressed in p53 TSD/-MEFs, but at much lower levels than in p53 +/+ MEFs ( Supplementary Information, Fig. S1f ). Although the p53 TSD/-mice were born with an expected Mendelian frequency and were similar to their wild-type littermates by 2 weeks of age, these mice became runted and weighed about 50% of the sex-and age-matched p53 +/+ -and p53 +/--mice by 4 weeks of age (Fig. 1a, b) . When compared with p53 +/+ mice, p53 TSD/-mice had a significantly shorter lifespan and died by 6 weeks of age (Fig. 1c) . Furthermore, p53 TSD/-mice exhibited a number of ageing-related phenotypes, including acute spine curvature (Fig. 1d) , hypoplasia in the bone marrow (Fig. 2a) and lymphopenia and anaemia (Fig. 2c, d ).
p53-dependent gene expression was analysed in the liver of newborn, and the thymus of three-week-old, p53 TSD/--and wild-type-mice. The expression of most p53-target genes was increased in p53 TSD/-cells, indicating that p53 is constitutively active (Fig. 1e and Supplementary Information, Fig. S2 ). In the thymus of p53 TSD/-mice, the mRNA levels of p53-target genes (p21 and Puma) were markedly increased, compared with other p53-target cell-cycle genes (Bax and 14-3-3σ). Consistent with the increased expression of p53 targets, such as Puma in p53 TSD/-thymocytes, the number of thymocytes was markedly reduced in p53 TSD/-mice when compared with wild-type controls (Fig. 1f) . The cause of thymocyte reduction is probably intrinsic because thymocyte number is already reduced in one-week-old p53 TSD/-mice when no other ageing phenotypes are apparent.
To confirm that the increased p53 activity is not limited to the lymphoid tissues, the expression of p53-target genes p21 and Puma in different tissues of p53 TSD/-and wild-type mice were compared, including in One-week-old TSD/-and p53 +/-MEFs were infected with retroviral-Cre to excise the PGK-Neo r cassette from the targeted allele. p53 was immunoprecipitated, and the amount of p53 and Mdm2 in the immunoprecipitate was determined by western blotting. Nonspecific antibody (control) was used to indicate the specificity of immunoprecipitation. The ratio of the protein levels of p53 and Mdm2 in the immunoprecipitates from the different mice strains is indicated. (h) Nutlin, which inhibits the interaction between p53 and Mdm2, can stabilize p53 TSD and make it more stable than wild-type p53. After deletion of PGK-Neo r from the targeted allele, p53 TSD/- and p53 +/-MEFs were treated with nutlin (25 μM) for 24 h, and then further cultured in medium containing cycloheximide (CHX; 10 μM), but without nutlin. The protein levels of p53 in untreated samples, nutlin-treated samples before cycloheximide treatment (0 h), and samples at the indicated times after cycloheximide treatment, were analysed by western blotting.
brain, kidney, small intestine, liver, lung, skin and spleen. The mRNA levels of Puma and p21 were increased in most tissues of p53 TSD/-mice, indicating that p53 is constitutively active in p53 TSD/-mice ( Supplementary  Information, Fig. S2 ). As expected from previous findings 2, 5 , the TSD mutation partially disrupted the interaction between p53 and its negative regulator Mdm2, accounting for the increased p53 stability and activity in p53 TSD/-cells ( TSD/-mice, and was essentially depleted in the bone marrow of 14-day-old p53 TSD/-mice. Consistent with this, lymphopenia was apparent in two-week-old p53 TSD/-mice ( Fig. 2c) . Furthermore, p53 TSD/-mice became progressively anaemic (Fig. 2d ). The defects in the haematopoietic stem cells (HSCs) of p53 TSD/-mice were cell autonomous, because unlike wild-type mice, the fetal-liver cells of p53 TSD/-mice failed to rescue lethally irradiated mice by repopulation of the haematopoietic system (data not shown). Therefore, bone-marrow failure is a probable cause of the shortened life span of p53 TSD/-mice. Adult neural stem cells/progenitor cells have been identified in the dentate gyrus of the hippocampus of mice and are progressively depleted during ageing 12 . To examine the effect of increased p53 activity on adult neural stem cells and their progeny, we employed the immature neuronal marker, doublecortin (DCX), and neuron-specific nucleic-acid marker, NeuN, to investigate neurogenesis in p53 TSD/-mice. Furthermore, the cells undergoing proliferation in the dentate gyrus, another marker for self-renewing adult neural stem cells, were detected by an antibody specific for Ki67, a nuclear antigen associated with cellular proliferation. The depletion of Ki67-positive and DCX-positive cells in the dentate gyrus suggests a marked depletion of the adult neural stem cells and their progeny in the dentate gyrus of onemonth-old p53 TSD/-mice ( Fig. 3a) . Using Sox2, a marker specific for adult neural stem cells, we confirmed that neural stem cells are depleted in the dentate gyrus of one-month-old p53 TSD/-mice (Fig. 3b) . Spermatogenesis is mediated by continuous self-renewal and differentiation of spermatogonial stem cells (SSCs), a process compromised during ageing 13 . SSCs are a very small subpopulation of spermatogonia lining the inner membrane of the seminiferous tubules of the testes. Although the size of the testes in wild-type and p53 +/-mice similarly increased with age (postnatal day 7 to 21), the size of the p53 TSD/-mice testes became increasingly smaller (Fig. 4a, b) . The impaired spermatogenesis was because of the decreased number of SSCs (Epcam + , α6-integrin + and c-Kit -) in the testes of p53 TSD/-mice (Fig. 4c) . Additionally, the apoptosis of the spermatogonia in the seminiferous tubules of p53 TSD/-mice was greatly increased when compared with that in wild-type-and p53 +/--mice (Fig. 4d, e) . Therefore, SSCs are depleted in the testes of p53 TSD/-mice probably as a result of increased apoptosis.
As the expression of p21 and Puma is increased in various tissues of p53 TSD/-mice, which is required for p53-mediated cell-cycle arrest and apoptosis, p21 -/--and Puma -/--mice were used to examine the importance of p53-dependent cell-cycle arrest and apoptosis in depleting adult stem cells. p21 deficiency fails to rescue the ageing-related phenotypes and early death of the p53 TSD/-mice ( Supplementary Information, Fig.  S3 ). In contrast, Puma-deficiency rescues the segmental progeria phenotypes observed in p53 TSD/-mice. Four-month-old p53 TSD/-Puma -/-mice were phenotypically similar to wild-type mice (Fig. 5a ). p53
mice are also similar to wild-type mice in growth rate (Fig. 5b) , and all p53 TSD/-Puma -/-mice survived longer than 6 weeks of age, whereas all p53 TSD/-mice died (Fig. 5c) . Furthermore, Puma-deficiency rescued the atrophy of testes, and prevented the depletion of adult stem cells in the bone marrow, testes and brain of p53 TSD/-mice (Figs 3a, b and 5d, f and Supplementary Information, Fig. S4 ). Puma-deficiency also prevented anaemia and partially rescued the thymocyte-reduction phenotype in p53 TSD/-mice ( Fig. 5e and Supplementary Information, Fig. S4d ).
Consistent with the critical roles of Puma in p53-dependent apoptosis, Puma-deficiency inhibited the apoptosis of spermatogonia in p53 TSD/-mice (Fig. 5g, h ). Confirming that p53 is constitutively active in p53 TSD/-thymocytes, ionizing radiation failed to increase p53-dependent apoptosis and p53-dependent transcription in p53 TSD/-thymocytes (Fig. 5i) . The partial rescue of thymocytes by Puma-deficiency is probably due to the increased expression of other p53-target genes such as p21 and Bax in the thymus of p53 TSD/-Puma -/-mice (Fig. 5j) . Furthermore, the greatly increased apoptosis of cells in the small intestinal crypt that leads to the degeneration of small intestine in p53 TSD/-mice is suppressed by Puma deficiency ( Supplementary Information, Fig. S5 ). These findings suggest that p53-dependent apoptosis has an important role in depleting adult stem cells in response to the accumulation of DNA damage.
Although accumulation of DNA damage has been shown to be associated with normal ageing [14] [15] [16] , it remains unclear how DNA damage induces ageing processes. As a critical component in activating cellular responses to DNA damage, the role of p53 in ageing also remains unclear because of the conflicting data from previous transgenic mouse studies. Two studies have shown that mutant mice with increased p53 activity (by expression of a p53 mutant with a truncated amino terminus) develop accelerated ageing phenotypes 17, 18 . However, normal ageing is observed in mice that have additional copies of the p53 or ARF gene, or a hypomorphic mutation in Mdm2, despite increased p53 activity [19] [20] [21] . Recent studies showed that transgenic mice with additional copies of both p53 and ARF genes live longer than wild-type mice 22 . The delayed ageing in these transgenic mice is correlated with decreased accumulation of DNA damage in aged mice. However, DNA damage accumulates during ageing in a physiological setting 1 . Therefore, the complex roles of p53 in DNA damage responses during mammalian ageing remain to be established. By generating a knock-in mouse model with a genetically modified p53 that mimics DNA-damage-activated p53, we show that increased p53 activity leads to segmental progeria and depletion of adult stem cells, suggesting a role for p53 in coordinating tissue regenerative capability and accumulated DNA damage. Together with the findings that p53 inhibits the self-renewal of DNA-damaged embryonic stem cells and that p53-deficient embryonic stem cells are genetically unstable 7, 23 , these findings suggest a universal role for p53 in maintaining genetic stability in stem cells by eliminating DNA-damaged cells from the selfrenewing pool. These findings also have implications for the current effort to develop cancer therapies by activating p53 in human cancer cells that harbour wild-type, but inactive, p53. Considering the critical roles of Mdm2 in destabilizing and suppressing p53 activity, and the frequent overexpression of Mdm2 in human cancer cells, the disruption of the interaction between Mdm2 and p53 has been an extensively pursued therapeutic strategy to activate p53 in cancer cells 24 . Our findings indicate that it is important to evaluate the long-term toxicity of the potential anti-Mdm2 therapy resulting from the depletion of adult stem cells.
One of the key findings from this study is the discovery of the critical roles for Puma in the depletion of adult stem cells induced by constitutively active p53. As Puma is a p53 transcription target required for p53-dependent apoptosis after DNA damage 6 , this finding suggests that p53-dependent apoptosis could have an important role in ageing by depleting adult stem cells when DNA damage is accumulated in the organism. In support of this, apoptosis is increased with normal ageing 20 . As p53 is critical for tumour suppression in humans, it would be impractical to develop a strategy to maintain adult stem cells by directly targeting p53. Along with previous findings that Puma-deficiency does not increase the cancer risk in mice 25, 26 , our results provide a feasible target to prevent depletion of adult stem cells in human patients with defective DNA repair pathways or patients undergoing radiation or chemotoxic cancer therapy. 
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METHODS
Generation of p53TSD knock-in mice.
A mouse p53 genomic fragment containing exon 2 was cloned into pBluescript, and the codons for Thr 21 and Ser 23 were simultaneously mutated to aspartic acid (from ACA and TCA to GAT). The LoxP site-flanked PGK-neomycin resistance gene was inserted into intron 4. The targeting vector was linearized with XbaI and electroporated into the mouse embryonic stem cells. Geneticin (G418)-resistant colonies were expanded and homologous recombinants were identified by Southern blotting analysis. The heterozygous mutant embryonic stem cells were used to generate chimaeric mice, which transmitted the mutant allele into mouse germline.
Cell culture conditions. Mouse embryonic fibroblasts were isolated from embryonic day 13 embryos as previously described 21 , and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS; Hyclone, Logan, Utah), 1% (w/v) antibiotics and 55 μM β-mecaptoethanol (Invitrogen). Saos-2 cells were maintained in DMEM supplemented with 10% (v/v) FBS (Hyclone), 55μM β-mercaptoethanol (Invitrogen) and 1% (w/v) antibiotics (Invitrogen) at 37 °C in a humidified incubator containing 5% CO 2 .
Histology analysis. Tissues were harvested from the euthanized mice, fixed in 10% (w/v) buffered formalin, embedded in paraffin and sectioned. Sections were stained with haematoxylin and eosin for histological assessment. X-ray images of euthanized animals were taken using a Faxitron X-ray system.
Statistical methods.
For the survival curve, Prism5 software (GraphPad) was used to generate the Kaplan-Meier survival curve. For most presented data, mean values from multiple independently obtained data are shown with s.d. Two-tailed P values were obtained from a t-test with paired or unpaired samples using Excel (Microsoft).
Determination of haemoglobin concentration in mouse blood. Blood samples were collected by Micro-Hematocrit capillary tubes (Fisher Scientific) from the tail veil, and diluted 1:100 to determine the haemoglobin concentration. Mouse haemoglobin was determined by QuantiChrom Hemoglobin Assay Kit (BioAssay Systems) according to manufacturer's instructions.
Western blotting analysis and co-immunoprecipitation. Protein extracts were resolved on SDS-PAGE gel and transferred to nitrocellulose membrane, which was probed with antibodies against p53 (1:1000; FL393, Santa Cruz Biotechnology), or actin (1:2000; Santa Cruz Biotechnology) or Mdm2 (1:500; Santa Cruz Biotechnology). The membrane was subsequently probed with a horseradish peroxidase-conjugated secondary antibody and developed with ECL PLUS (Amersham). For the co-immunoprecipitation assay, cells were harvested and lysed in lysis buffer (20mM Tris, pH 7.6, 1 mM EDTA, 150 mM NaCl, 0.5% (v/v) NP-40, 10 mM NaF, 1 mM NaVO 4 ,10% (v/v) glycerol and proteinase inhibitor). Whole cell protein extracts (1-3 mg) were immunoprecipitated with polyclonal antibody against p53 (1:1000; FL393, Santa Cruz Biotechnology), followed by incubating with protein-G conjugated beads (Amersham) overnight at 4 °C. The beads were washed three times with lysis buffer and boiled with 1 × SDS loading buffer for 5 min. The amount of p53 and Mdm2 in the immunoprecipitate was analysed by western blotting. For detecting the immunoprecipitated p53, the secondary antibody is the Rabbit Trueblot (eBioscience) with 1:5,000 dilutions.
Quantitative real-time PCR. Total RNA from MEFs or mouse tissues was isolated using Trizol (Invitrogen) and RNAeasy Mini Kit (Qiagen). Total RNA (1 μg) was reverse-transcribed into cDNA using Superscript II RT kit (Invitrogen). Quantitative PCR was performed with an ABI Prism 7000 (Applied Biosystems) with Power SybrGreen PCR Master Mix (Applied Biosystems). PCR conditions were as follows: 10 min hot-start at 95 °C followed by 40 cycles of 30 s at 95 °C and 1 min at 60 °C . The levels of gene expression were normalized with the mRNA levels of GAPDH as previously described 9 . The sequence of the PCR primers are: p21, 5ʹ-ATGTCCAATCCTGGTGATGT-3ʹ and 5ʹ-TGCAGCAGGGCAGAGGAAGT-3ʹ; killer5, 5ʹ-CGTCTCA T G-CGGCAGTTG-3ʹ and 5ʹ-TCGGCTTT GACCATTTGGA-3ʹ; Puma 5ʹ-CGACCT-CAA CGCGCAGTA-3ʹ and 5ʹ-AGTCCCATGAAGAGATTGTACATGAC-3ʹ; Bax, 5ʹ-ATGCGTCCACCAAGAAGCTGA-3ʹ and 5ʹ-AGCAATC ATCCTCT-GCA GCTCC-3ʹ; GAPDH, 5ʹ-AATGT GTCCGTCGTGGATCTGA-3ʹ and 5ʹ-GATGC CT GCTTCACCA CCTTCT-3ʹ; Noxa, 5ʹ-CCACCTGA-GTTC GCAG CTCAA-3ʹ and 5ʹ-GTTGAGCACA CTC GTCCTTCAA-3ʹ; Mdm2, 5ʹ-ATTGCCTGGATCAGGATTCAGTT-3ʹ and 5ʹ-ACCTCATCA-TCCTCATC TGAGA-3ʹ; Perp, 5ʹ-TCATCCTGT GCATCT GCTTC-3ʹ and 5ʹ-GGGTTATCGTGAAGCCTGAA-3ʹ; 14-3-3δ, 5ʹ-GCCGAACGGTAT-GAAGACAT-3ʹ and 5ʹ-CTCCTCGTTGCTCTTCTGCT-3ʹ; Fas, 5ʹ-CCAAG-ACACA G CTGAGCAGAAA-3ʹ and 5ʹ-CTCTTC CCATGAGATTGGTA CCA-3ʹ; GADD45, 5ʹ-TGGTGACGAACCCACATTCAT-3ʹ and 5ʹ-ACCCACTGA-TCCATGTAGCGAC-3ʹ; Tigar, 5ʹ-CTTCGCCT TGACCG TTAT-3ʹ and 5ʹ-TGTATGGTCTGC TTAGTCCTC-3ʹ; ALDH4, 5ʹ-AGTCTACT GGGTCT-GTGGTG-3ʹ and 5ʹ-GGCTTATGAGTCTCCTTGAT-3ʹ.
Flow cytometry analysis of haematopoietic and spermatogonia stem cells.
Haematopoietic stem cells were analysed as previously described 27 . Briefly, bone marrow cells were isolated, filtered and incubated with biotinylated anti-lineagemarker antibodies (CD3, B220, CD11b, Ly-6G and TER119; 1:50; eBioscience). After 15 min of incubation on ice, the cells were washed twice and incubated with phycoerythrin-anti-c-kit antibody, FITC-anti-Sca-1 antibody (1:200) and APCstreptavidin (0.5 μg per million cells; eBioscience) for 15 min on ice, followed by washing twice with PBS supplemented with 3% (v/v) fetal bovine serum. The stained cells were analysed on a BD LSRII system (BD bioscience). For the isolation of haematopoietic stem/progenitor cells, the bone marrow cells were incubated with the biotinylated anti-lineage markers antibodies, followed by streptavidinconjugated magnetic beads (Dynabeads) to eliminate lineage marker positive cells. Negatively selected cells were incubated with biotinylated anti-Sca-1 and anti-c-Kit antibodies (1:50; eBioscience), followed by incubation with streptavidin-conjugated magnetic beads to purify haematopoietic stem/progenitor cells.
Spermatogonia in the testes were isolated as previous described 28 . Briefly, testes were dissociated by digesting with 1 mg ml -1 collagenase (Sigma), followed by the treatment with trypsin containing 5 U ml Supplementary data: Uncropped gel scan
